Artivion, Inc. (AORT)
USD 27.79
(-3.84%)
USD 27.79
(-3.84%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 510.61 Million USD | 6.72% |
| 2022 | 478.46 Million USD | -2.81% |
| 2021 | 492.32 Million USD | 6.87% |
| 2020 | 460.69 Million USD | 43.98% |
| 2019 | 319.95 Million USD | 8.09% |
| 2018 | 296.02 Million USD | -5.31% |
| 2017 | 312.63 Million USD | 191.75% |
| 2016 | 107.15 Million USD | 313.29% |
| 2015 | 25.92 Million USD | -5.62% |
| 2014 | 27.47 Million USD | -8.23% |
| 2013 | 29.93 Million USD | 3.07% |
| 2012 | 29.04 Million USD | 10.32% |
| 2011 | 26.32 Million USD | -89.53% |
| 2010 | 251.38 Million USD | 973.68% |
| 2009 | 23.41 Million USD | -12.21% |
| 2008 | 26.66 Million USD | -11.27% |
| 2007 | 30.05 Million USD | 8.21% |
| 2006 | 27.77 Million USD | 6.07% |
| 2005 | 26.18 Million USD | 10.96% |
| 2004 | 23.6 Million USD | -11.57% |
| 2003 | 26.68 Million USD | 0.28% |
| 2002 | 26.61 Million USD | -4.51% |
| 2001 | 27.87 Million USD | 23.25% |
| 2000 | 22.61 Million USD | 63.88% |
| 1999 | 13.79 Million USD | -23.34% |
| 1998 | 18 Million USD | -23.4% |
| 1997 | 23.5 Million USD | 132.67% |
| 1996 | 10.1 Million USD | 225.81% |
| 1995 | 3.1 Million USD | -11.43% |
| 1994 | 3.5 Million USD | 0.0% |
| 1993 | 3.5 Million USD | -31.37% |
| 1992 | 5.1 Million USD | 18.6% |
| 1991 | 4.3 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 489.02 Million USD | -4.23% |
| 2024 Q2 | 494.48 Million USD | 1.12% |
| 2023 Q2 | 495.35 Million USD | 3.81% |
| 2023 FY | 510.61 Million USD | 6.72% |
| 2023 Q4 | 510.61 Million USD | 1.55% |
| 2023 Q3 | 502.81 Million USD | 1.51% |
| 2023 Q1 | 477.15 Million USD | -0.27% |
| 2022 Q4 | 478.46 Million USD | -1.88% |
| 2022 Q2 | 483.35 Million USD | -0.21% |
| 2022 Q3 | 487.62 Million USD | 0.88% |
| 2022 FY | 478.46 Million USD | -2.81% |
| 2022 Q1 | 484.36 Million USD | -1.62% |
| 2021 Q2 | 508.66 Million USD | 2.24% |
| 2021 Q3 | 507.11 Million USD | -0.3% |
| 2021 Q4 | 492.32 Million USD | -2.92% |
| 2021 Q1 | 497.5 Million USD | 7.99% |
| 2021 FY | 492.32 Million USD | 6.87% |
| 2020 Q4 | 460.69 Million USD | 0.93% |
| 2020 Q1 | 344.42 Million USD | 7.65% |
| 2020 Q3 | 456.43 Million USD | 15.06% |
| 2020 Q2 | 396.69 Million USD | 15.18% |
| 2020 FY | 460.69 Million USD | 43.98% |
| 2019 FY | 319.95 Million USD | 8.09% |
| 2019 Q2 | 314.97 Million USD | 0.21% |
| 2019 Q4 | 319.95 Million USD | 1.54% |
| 2019 Q3 | 315.1 Million USD | 0.04% |
| 2019 Q1 | 314.3 Million USD | 6.18% |
| 2018 Q4 | 296.02 Million USD | 1.07% |
| 2018 Q3 | 292.88 Million USD | -2.03% |
| 2018 FY | 296.02 Million USD | -5.31% |
| 2018 Q2 | 298.96 Million USD | -1.07% |
| 2018 Q1 | 302.18 Million USD | -3.34% |
| 2017 Q3 | 102.78 Million USD | -0.36% |
| 2017 Q1 | 105.93 Million USD | -1.14% |
| 2017 Q2 | 103.16 Million USD | -2.62% |
| 2017 FY | 312.63 Million USD | 191.75% |
| 2017 Q4 | 312.63 Million USD | 204.17% |
| 2016 FY | 107.15 Million USD | 313.29% |
| 2016 Q3 | 104.69 Million USD | -0.23% |
| 2016 Q2 | 104.93 Million USD | 1.88% |
| 2016 Q1 | 102.99 Million USD | 297.24% |
| 2016 Q4 | 107.15 Million USD | 2.35% |
| 2015 Q4 | 25.92 Million USD | -7.69% |
| 2015 FY | 25.92 Million USD | -5.62% |
| 2015 Q1 | 24.35 Million USD | -11.36% |
| 2015 Q2 | 26.52 Million USD | 8.93% |
| 2015 Q3 | 28.08 Million USD | 5.89% |
| 2014 Q2 | 27.84 Million USD | -0.36% |
| 2014 Q4 | 27.47 Million USD | -2.92% |
| 2014 FY | 27.47 Million USD | -8.23% |
| 2014 Q3 | 28.29 Million USD | 1.63% |
| 2014 Q1 | 27.94 Million USD | -6.64% |
| 2013 Q2 | 27 Million USD | 9.17% |
| 2013 Q3 | 28.65 Million USD | 6.11% |
| 2013 FY | 29.93 Million USD | 3.07% |
| 2013 Q4 | 29.93 Million USD | 4.48% |
| 2013 Q1 | 24.73 Million USD | -14.84% |
| 2012 Q1 | 26.1 Million USD | -0.85% |
| 2012 Q4 | 29.04 Million USD | 5.33% |
| 2012 Q2 | 32.35 Million USD | 23.96% |
| 2012 Q3 | 27.57 Million USD | -14.78% |
| 2012 FY | 29.04 Million USD | 10.32% |
| 2011 Q3 | 27.22 Million USD | 11.27% |
| 2011 FY | 26.32 Million USD | -89.53% |
| 2011 Q4 | 26.32 Million USD | -3.29% |
| 2011 Q2 | 24.46 Million USD | 6.25% |
| 2011 Q1 | 23.02 Million USD | -2.01% |
| 2010 FY | 251.38 Million USD | 973.68% |
| 2010 Q1 | 24.17 Million USD | 3.26% |
| 2010 Q2 | 24.16 Million USD | -0.07% |
| 2010 Q4 | 23.49 Million USD | 6.19% |
| 2010 Q3 | 22.12 Million USD | -8.42% |
| 2009 Q1 | 25.18 Million USD | -5.56% |
| 2009 Q4 | 23.41 Million USD | -6.49% |
| 2009 Q3 | 25.03 Million USD | -0.58% |
| 2009 Q2 | 25.18 Million USD | 0.0% |
| 2009 FY | 23.41 Million USD | -12.21% |
| 2008 Q1 | 24.65 Million USD | -17.97% |
| 2008 Q4 | 26.66 Million USD | 0.46% |
| 2008 FY | 26.66 Million USD | -11.27% |
| 2008 Q3 | 26.54 Million USD | 0.39% |
| 2008 Q2 | 26.44 Million USD | 7.24% |
| 2007 Q4 | 30.05 Million USD | -4.99% |
| 2007 FY | 30.05 Million USD | 8.21% |
| 2007 Q1 | 30.38 Million USD | 9.39% |
| 2007 Q2 | 31.06 Million USD | 2.24% |
| 2007 Q3 | 31.63 Million USD | 1.83% |
| 2006 Q1 | 28.11 Million USD | 7.36% |
| 2006 FY | 27.77 Million USD | 6.07% |
| 2006 Q4 | 27.77 Million USD | -4.19% |
| 2006 Q3 | 28.99 Million USD | 3.43% |
| 2006 Q2 | 28.03 Million USD | -0.3% |
| 2005 Q3 | 43.8 Million USD | -13.77% |
| 2005 Q2 | 50.8 Million USD | 75.89% |
| 2005 Q1 | 28.88 Million USD | 22.37% |
| 2005 FY | 26.18 Million USD | 10.96% |
| 2005 Q4 | 26.18 Million USD | -40.22% |
| 2004 FY | 23.6 Million USD | -11.57% |
| 2004 Q3 | 26.9 Million USD | -11.06% |
| 2004 Q2 | 30.25 Million USD | 15.13% |
| 2004 Q4 | 23.6 Million USD | -12.28% |
| 2004 Q1 | 26.27 Million USD | -1.55% |
| 2003 Q1 | 21.22 Million USD | -20.26% |
| 2003 FY | 26.68 Million USD | 0.28% |
| 2003 Q4 | 26.68 Million USD | -14.47% |
| 2003 Q3 | 31.2 Million USD | -16.91% |
| 2003 Q2 | 37.55 Million USD | 76.97% |
| 2002 Q2 | 25.07 Million USD | 8.16% |
| 2002 Q1 | 23.18 Million USD | -16.81% |
| 2002 Q3 | 22.21 Million USD | -11.42% |
| 2002 FY | 26.61 Million USD | -4.51% |
| 2002 Q4 | 26.61 Million USD | 19.81% |
| 2001 Q4 | 27.87 Million USD | 16.07% |
| 2001 Q2 | 25.04 Million USD | 10.99% |
| 2001 Q3 | 24.01 Million USD | -4.11% |
| 2001 Q1 | 22.56 Million USD | -0.23% |
| 2001 FY | 27.87 Million USD | 23.25% |
| 2000 Q3 | 20.58 Million USD | 30.49% |
| 2000 Q1 | 14.43 Million USD | 4.63% |
| 2000 FY | 22.61 Million USD | 63.88% |
| 2000 Q4 | 22.61 Million USD | 9.84% |
| 2000 Q2 | 15.77 Million USD | 9.27% |
| 1999 Q4 | 13.79 Million USD | -15.34% |
| 1999 Q2 | 16.6 Million USD | -0.6% |
| 1999 Q1 | 16.7 Million USD | -7.22% |
| 1999 FY | 13.79 Million USD | -23.34% |
| 1999 Q3 | 16.3 Million USD | -1.81% |
| 1998 Q3 | 20.1 Million USD | 54.62% |
| 1998 Q2 | 13 Million USD | -51.85% |
| 1998 FY | 18 Million USD | -23.4% |
| 1998 Q1 | 27 Million USD | 14.89% |
| 1998 Q4 | 18 Million USD | -10.45% |
| 1997 Q2 | 20.6 Million USD | -2.37% |
| 1997 Q3 | 22.8 Million USD | 10.68% |
| 1997 Q4 | 23.5 Million USD | 3.07% |
| 1997 Q1 | 21.1 Million USD | 108.91% |
| 1997 FY | 23.5 Million USD | 132.67% |
| 1996 Q4 | 10.1 Million USD | 24.69% |
| 1996 Q1 | 3.7 Million USD | 19.35% |
| 1996 FY | 10.1 Million USD | 225.81% |
| 1996 Q2 | 4.5 Million USD | 21.62% |
| 1996 Q3 | 8.1 Million USD | 80.0% |
| 1995 Q3 | 4.4 Million USD | 4.76% |
| 1995 Q4 | 3.1 Million USD | -29.55% |
| 1995 Q2 | 4.2 Million USD | 10.53% |
| 1995 FY | 3.1 Million USD | -11.43% |
| 1995 Q1 | 3.8 Million USD | 8.57% |
| 1994 Q2 | 3.5 Million USD | 0.0% |
| 1994 Q3 | 3.3 Million USD | -5.71% |
| 1994 Q4 | 3.5 Million USD | 6.06% |
| 1994 FY | 3.5 Million USD | 0.0% |
| 1994 Q1 | 3.5 Million USD | 0.0% |
| 1993 Q2 | 2.5 Million USD | 0.0% |
| 1993 FY | 3.5 Million USD | -31.37% |
| 1993 Q4 | 3.5 Million USD | 9.38% |
| 1993 Q3 | 3.2 Million USD | 28.0% |
| 1992 FY | 5.1 Million USD | 18.6% |
| 1992 Q4 | 5.1 Million USD | 0.0% |
| 1991 FY | 4.3 Million USD | 0.0% |
| 1991 Q4 | 4.3 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott Laboratories | 34.38 Billion USD | 98.515% |
| Allurion Technologies Inc. | 142.19 Million USD | -259.086% |
| Avanos Medical, Inc. | 456.1 Million USD | -11.953% |
| Butterfly Network, Inc. | 84.22 Million USD | -506.282% |
| Butterfly Network, Inc. | 84.22 Million USD | -506.282% |
| Bio-Rad Laboratories, Inc. | 3.55 Billion USD | 85.649% |
| Boston Scientific Corporation | 15.6 Billion USD | 96.728% |
| Perspective Therapeutics, Inc. | 3.44 Million USD | -14704.784% |
| CONMED Corporation | 1.46 Billion USD | 65.165% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | 80.686% |
| Paragon 28, Inc. | 162.95 Million USD | -213.343% |
| Glaukos Corporation | 478.64 Million USD | -6.679% |
| Globus Medical, Inc. | 1.08 Billion USD | 53.074% |
| Inspire Medical Systems, Inc. | 104.29 Million USD | -389.58% |
| Integer Holdings Corporation | 1.41 Billion USD | 63.869% |
| Medtronic plc | 39.56 Billion USD | 98.709% |
| Nevro Corp. | 330.31 Million USD | -54.587% |
| Owlet, Inc. | 73.79 Million USD | -591.902% |
| Penumbra, Inc. | 377.36 Million USD | -35.313% |
| Vicarious Surgical Inc. | 21.89 Million USD | -2232.117% |
| Smith & Nephew plc | 4.77 Billion USD | 89.295% |
| Sonendo, Inc. | 49.74 Million USD | -926.552% |
| STERIS plc | 4.74 Billion USD | 89.246% |
| Stryker Corporation | 21.31 Billion USD | 97.605% |
| Vapotherm, Inc. | 132.95 Million USD | -284.064% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | 94.332% |